Summary of Significant Accounting Policies (Details) |
3 Months Ended | ||||
|---|---|---|---|---|---|
|
Mar. 31, 2026
USD ($)
|
Mar. 31, 2026
USD ($)
|
Mar. 31, 2026
USD ($)
segment
|
Mar. 31, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
|
|
| Summary of Significant Accounting Policies [Line Items] | |||||
| Cash and cash equivalents | $ 10,002,477 | $ 10,002,477 | $ 10,002,477 | $ 7,176,615 | |
| Accumulated deficit | (34,971,676) | (34,971,676) | (34,971,676) | (21,114,473) | |
| Federal depository insurance coverage | 250,000 | 250,000 | 250,000 | ||
| Impairment expense | 2,045,253 | ||||
| R&D costs | 321,271 | ||||
| Share-based compensation | 5,107,399 | 1,952,852 | |||
| Warrant liabilities | 7,714,794 | $ 7,714,794 | $ 7,714,794 | $ 53,000 | |
| Fair value of warrants | 2,314,353 | $ (13,515) | |||
| Number of reportable segments | 2 | 1 | |||
| Warrant [Member] | |||||
| Summary of Significant Accounting Policies [Line Items] | |||||
| Warrant liabilities | 7,714,794 | $ 7,714,794 | $ 7,714,794 | ||
| Fair value of warrants | $ 2,314,353 | ||||
| X | ||||||||||
- Definition The amount of impairment expense. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|